Santen Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
19,718
24,032
53,373
21,724
35,261
31,943
Depreciation, Depletion & Amortization
2,841
6,958
9,338
9,882
10,896
10,969
Other Funds
322
194
490
167
408
5,826
Funds from Operations
27,815
31,596
31,657
18,200
43,706
37,088
Changes in Working Capital
1,129
6,210
9,132
7,357
863
4,194
Net Operating Cash Flow
26,686
25,386
22,525
10,843
42,843
32,894
Capital Expenditures
5,879
66,440
9,092
9,500
9,937
Sale of Fixed Assets & Businesses
2
656
45,696
836
838
Purchase/Sale of Investments
1,911
4,135
472
905
2,314
Net Investing Cash Flow
7,847
61,709
37,052
27,369
7,421
Cash Dividends Paid - Total
8,247
8,264
9,923
10,751
10,559
Issuance/Reduction of Debt, Net
29
37,030
14,633
6,524
8,316
Net Financing Cash Flow
7,954
28,960
24,066
29,489
18,469
Net Change in Cash
12,160
6,474
33,875
47,516
17,001
Free Cash Flow
23,225
22,414
18,226
6,698
38,859
Net Assets from Acquisitions
-
-
-
19,064
-
Change in Capital Stock
-
-
-
12,380
1
Exchange Rate Effect
1,275
889
1,636
1,501
48
Other Uses
59
60
24
545
636
About Santen Pharmaceutical Co.
View Profile
